Boris C. Bastian, MD, PhD: Mutations To Test For in Melanoma
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Suggested videos

Dr. Monk on the Utility of Bevacizumab for Cervical Cancer
Targeted Onc · 1:47

Boris C. Bastian, MD, PhD: BioMérieux and Other Tests
Targeted Onc · 1:00

Dr. Bollard Discusses T Cell Resistance to TGF-Beta in Lymphoma
Targeted Onc · 2:10

Boris C. Bastian, MD, PhD: Frequency of Missed BRAF Alterations
Targeted Onc · 3:57

ALK+ NSCLC: PFS and Activity in CNS, Dosing, & Toxicity
Targeted Onc · 2:06

Molecular stratification of melanoma and the high burden of mutations
ecancer · 1:10

Treatment Approach for Nondriver Lung Adenocarcinoma
Targeted Onc · 7:12

Adil Daud, MD: Optimal Sequencing for BRAF-Mutant Melanoma Patients
Targeted Onc · 1:32

The Future of Cancer Research: Insights From Dr Ferris
Targeted Onc · 4:40

Tailoring Therapy for Patients With DLBCL
Targeted Onc · 2:01

Tackling Some of The Challenges That Remain in Pancreatic Cancer
Targeted Onc · 1:27

Recent Milestones in the Field of RCC
Targeted Onc · 1:32